The launch marks Aurobindo Pharma’s entry into the US inhalation market and expands its complex generics portfolio beyond conventional oral solid formulations
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.